Company Overview

Novaicos is the acronym of Novara and ICOS the molecule studied within the company. Novaicos Srls was founded in May 2016 as and Academic Spin-off company by a group of researcher from University of Novara and University of Torino. NOVAICOS is an innovative Start Up

Novaicos’ approach

All the innovations in medical field were born from collaboration between industries, clinicians and researcher worldwide. Novaicos’ team strongly believe that this is the correct way to achieve great goals in a real innovation and are devoted to translational research that involves different professional figures.


• Start Cup Piemonte and Valle dAosta Award 2015
• Award Novara Incubator of Innovative Enterprises, offered by the Banco Popolare di Novara
• Project Award Global grant  for innovative start-ups spin off of public research POR FSE 2014/2020 Assigned by FINPIEMONTE
• Horizon 2020 with Giotto (Active aGeIng and Osteoporosis: The next challenge for smarT nanobiOmaterials and 3D technologies) funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 814410
• Candidates supported by Novaicos have won the ” Borsa dei Talenti della Società Civile” promoted by Fondazione Goria and Fondazione CRT for the years 2019 and 2020

Luca Gigliotti PhD

President, CEO/CSO
lab coordinator and responsible for biomaterials.

Degree in Biotechnologies for Human Health obtained in 2013, Second Level degree in Medical and Pharmaceutical Biotechnology at UPO obtained in 2009, from 2013 to date: Post Doc position in the laboratory of Immunology, UPO. He is co-author of 19 Publications in international journals, H-Index 7. Within Novaicos he is CEO, lab coordinator and responsible for biomaterials.

Prof. Umberto Dianzani, MD, PhD

R&D supervisor, Communication manager.

Degree with honors (Università di Torino) in 1984. PhD degree (Università di Genova) in 1990. Post-doctoral fellow at University of Alabama at Birmingham in 1985, and at Yale University in 1988-89. Associate professor of Immunology at University of Pisa (1992-93) and at Università del Piemonte Orientale at Novara (1993-99). From 1999, full professor of Immunology, Università del Piemonte Orientale at Novara. President of the Interdisciplinary Research Center of Autoimmune Diseases (2003-2010). Vice-rector for International Relations, Università del Piemonte Orientale (2011-2015). From 2012, head of the Department of Health Sciences, Università del Piemonte Orientale. Member of the Italian Society of Immunology Clinical Immunology and Allergy, the Italian Society of Pathology and Translational Medicine, the American Association of Immunologists, and the Medical Academy of Turin. Co-author of 153 scientific publications on immunology, oncoimmunology and autoimmune diseases. Total impact factor >800, H Index 35, total citations >4300. Within Novaicos he is R&D supervisor and Communication Manager.

Elena Boggio, PhD, CTO

Lab coordinator.

Degree in Molecular Medicine at Università del Piemonte Orientale (UPO) obtained in 2010: Novara, Second Level degree in Medical and Pharmaceutical Biotechnology at UPO, obtained in 2006, First Level degree in Biotechnology at UPO obtained in 2004. She is co-author of 17 Pubblications, H index6

Patrizia D’Amelio, MD,PhD

Clinical Area Manager

Associated Professor University of Lausanne, Geriatric and Geriatric Rehabilitation Unit, Centre Hospitalier Universitaire Vaudois (CHUV). She was Assistant Professor of Internal Medicine and Gerontology at the University of Torino, she founded a lab devoted to translational bone research in human model and described, for the first time in literature, osteoclastogenesis from peripheral blood cells in post-menopausal osteoporosis. Her main research interest is osteoimmunology and has several collaboration with European and extra-European scientists in the bone field. She is co-author of 54 articles in impact factor journal with more than 800 citation, she is in the editorial board of 5 interantional journals and associated editors of the Journal Clinical Reviews in Bone and Mineral Metabolism. She won 9 Young investigator awards, participated with invited lecture to more than 40 national and international meetings, is the owner of the patent TO2006A00565 for an image analyses software to detect osteoclast ability to resorb bone in vitro. Within Novaicos she is responsible for the clinical development.

Maurizio Michele Zuzzaro.

Financial Strategist

Maurizio M. Zuzzaro is the founder of the financial web site He was former director of the investment fund WDF SICAV PLC, has more than 10 years of experience as financial analyst within the market of value exchange and energy raw materials.

He is author and co-author of plenty of articles in the field of Technical Financial Analyses, member of the following societies: Italian Society for Techincal Analyst (SIAT), Italian Financial Markets Association (Assiom Forex). Within Novaicos he is financial strategist.

Company Structure

Scientific Advisory Board

Prof. Giancarlo Isaia – Full professor of Internal Medicine, Director of Bone and Geriatric Unit of the University of Torino. Clinical expert in bone metabolic disorders.

Prof.ssa Roberta Cavalli – Full Professor of Pharmaceutical Chemistry at the Dept of Drugs Science and Technology University of Torino – Coordinator of the Group Pharmaceutical and Cosmetic Technology (PHARCOTEC). Expert in formulations of nano-structured materials for therapeutic drugs delivery.

Prof. Josè Maria Rojo Hernandez – Director of the «Centro de Investigaciones Biologicas» and Researcher at the Dep. de Medicina Celular y Molecular in Madrid. Expert on immune system response and autoimmune diseases.

Prof. Junji Yagi – Full Professor al Women’s Medical University di Tokyo.Dept of Microbiology and Immunology-expert in dermathology and autoimmune diseases.